Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs Clopidogrel in Low/Moderate Stroke Risk Atrial Fibrillation
NCT02960126Phase 3Unknown
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- Nov 2016
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of aspirin in Atrial fibrillation (AFib), sponsored by Hallym University Chuncheon Sacred Heart Hospital. Status: unknown.
02
Drugs
aspirin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02960126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02960126.